PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.
Liu SH, Rao DD, Nemunaitis J, Senzer N, Zhou G, Dawson D, Gingras MC, Wang Z, Gibbs R, Norman M, Templeton NS, Demayo FJ, O'Malley B, Sanchez R, Fisher WE, Brunicardi FC.
Liu SH, et al. Among authors: brunicardi fc.
PLoS One. 2012;7(8):e40452. doi: 10.1371/journal.pone.0040452. Epub 2012 Aug 8.
PLoS One. 2012.
PMID: 22905092
Free PMC article.